You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 21, 2025

Drug Price Trends for NDC 00054-0639


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00054-0639

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
METHYLERGONOVINE MALEATE 0.2MG TAB Golden State Medical Supply, Inc. 00054-0639-05 12 217.69 18.14083 2023-06-15 - 2028-06-14 FSS
METHYLERGONOVINE MALEATE 0.2MG TAB Golden State Medical Supply, Inc. 00054-0639-05 12 182.21 15.18417 2023-10-11 - 2028-06-14 FSS
METHYLERGONOVINE MALEATE 0.2MG TAB Golden State Medical Supply, Inc. 00054-0639-13 28 507.94 18.14071 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 00054-0639

Understanding the National Drug Code (NDC)

The National Drug Code (NDC) is a unique, three-segment number used by the FDA to identify drugs. The NDC 00054-0639 is associated with a specific drug product, and understanding its components is crucial for market analysis and price projections.

Components of the NDC

  • Labeler Code: The first segment (00054) identifies the labeler or manufacturer of the drug.
  • Product Code: The second segment identifies the specific drug product.
  • Package Code: The third segment identifies the packaging configuration of the drug product[5].

Market Trends in the Pharmaceutical Industry

Global Pricing Disparities

The pharmaceutical industry is marked by significant pricing disparities across different regions. In the U.S., drug prices are substantially higher compared to other OECD countries and the rest of the world. For instance, in 2022, the average price per unit in the U.S. was 5.5 times higher than in OECD countries (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].

Impact of Technological Advancements

Technologies such as AI, gene editing, and blockchain are transforming the pharmaceutical industry. AI, in particular, is accelerating drug development by analyzing vast datasets and predicting drug success rates with high accuracy. This could lead to faster market entry and potentially lower development costs, which might influence pricing strategies[3].

Price Projections for NDC 00054-0639

Historical Pricing Data

To project future prices, it is essential to analyze historical pricing data. The NDC 00054-0639 would be identified and reported by its unique NDC code in databases such as the Red Book, which tracks average wholesale prices. From 2000 to 2008, many brand-name drug products experienced extraordinary price increases, with some increasing by over 2,000%[2].

Current Market Dynamics

The U.S. market has seen an average price increase of 14% between 2017 and 2022, while prices in other regions have decreased. This trend suggests that drugs in the U.S. market, including those identified by NDC 00054-0639, may continue to see price increases driven by factors such as research and development costs, market demand, and regulatory environments[4].

Factors Influencing Pricing

Several factors contribute to the pricing of drugs:

  • Perceived Value: The unique characteristics of the drug, such as ease of use and safety.
  • Therapeutic Class: Drugs in certain therapeutic classes, like central nervous system agents, tend to have higher price increases.
  • Patient Market: The size and characteristics of the patient market.
  • Reimbursement: The amount of reimbursement from third-party payers[2].

Regulatory Changes

The FDA's potential changes to the NDC format could impact the entire pharmaceutical supply chain. Transitioning from a 5-digit to a 6-digit labeler code, for example, would require significant updates to systems and could affect how drugs are tracked and priced[1].

Economic and Business Impacts

Supply Chain and Pharmacy Operations

Any changes to the NDC format will impact nearly every system in the healthcare sector, including pharmacy operations and the pharmaceutical supply chain. This could lead to temporary disruptions and additional costs for businesses to update their systems[1].

Market Competition

The introduction of new technologies and treatments can increase market competition. Companies that invest in digital skills and new technologies, such as AI and gene editing, may gain a competitive edge, potentially influencing pricing strategies and market positioning[3].

Predictive Analysis

Given the current trends and factors influencing drug pricing:

  • Short-Term Projections: Prices for the drug identified by NDC 00054-0639 are likely to continue increasing, albeit at a slower rate than in previous years, due to the overall market trends and regulatory stability.
  • Long-Term Projections: As AI and other technologies continue to reduce development costs and improve efficiency, there could be a stabilization or even a slight decrease in prices over the long term. However, this would depend on how these technologies are adopted and integrated into the industry.

Key Takeaways

  • Global Pricing Disparities: Drug prices in the U.S. are significantly higher than in other regions.
  • Technological Impact: AI and other technologies are transforming drug development and could influence pricing.
  • Regulatory Changes: Changes to the NDC format could impact the entire pharmaceutical supply chain.
  • Market Dynamics: Historical data and current market trends suggest continued price increases in the short term.
  • Long-Term Outlook: Potential stabilization or decrease in prices due to technological advancements.

FAQs

What is the significance of the National Drug Code (NDC)?

The NDC is a unique identifier used by the FDA to track and regulate drug products. It is crucial for ensuring the safety and security of drug products.

How do technological advancements impact drug pricing?

Technologies like AI can reduce development costs and speed up the drug development process, potentially leading to lower prices or more stable pricing over time.

Why are drug prices higher in the U.S. compared to other regions?

Drug prices in the U.S. are influenced by factors such as research and development costs, market demand, and reimbursement from third-party payers, leading to higher prices compared to other regions.

What are the potential impacts of changing the NDC format?

Changing the NDC format could impact nearly every system in the healthcare sector, requiring significant updates and potentially leading to temporary disruptions and additional costs.

How can companies prepare for future market trends in the pharmaceutical industry?

Companies should invest in digital skills and new technologies, prepare for stricter regulations, and focus on sustainable practices to maximize their market positioning and innovation capabilities.

Sources

  1. Wolters Kluwer: "Are You Prepared for a Major Industry Change to the National Drug Code (NDC) Number?"
  2. GAO: "Brand-Name Prescription Drug Pricing"
  3. Laboratorios Rubio: "The Future of Pharma: 2025's Key Trends To Know"
  4. ASPE: "International Market Size and Prices"
  5. FDA: "National Drug Code Directory"
Last updated: 2025-01-01

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.